| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |